{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:02:17Z","timestamp":1756771337892,"version":"3.44.0"},"reference-count":55,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2025.2025.0134","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T14:25:46Z","timestamp":1753280746000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Manifestations, Treatment Characteristics and Clinical Outcome in Patients with Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in the Real-World Setting: An Interim Analysis of the Turkish aTTP Registry"],"prefix":"10.4274","author":[{"given":"Sema","family":"Karaku\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eule Mine","family":"Bakanay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevgi","family":"Kalayo\u011flu Be\u015fi\u015fik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Emre","family":"E\u015fkazan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Ayy\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emel","family":"G\u00fcrkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkan","family":"Karaku\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nil","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffer","family":"Keklik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman \u0130lhami","family":"\u00d6zcebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahir","family":"\u00d6zkalemka\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vildan","family":"\u00d6zkocaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umut","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senem","family":"Dadin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Ali","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Karaku\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dcnal","family":"Ata\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00fctfullah Zahit","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eren","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibel","family":"Kabuk\u00e7u Hac\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ba\u015fak","family":"\u00dcnver Koluman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcls\u00fcm","family":"\u00d6zet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tekin","family":"G\u00fcney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Fidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fclay","family":"Karaa\u011fa\u00e7 Akyol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cevat \u0130lteri\u015f","family":"K\u0131k\u0131l\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Demirkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130rfan","family":"Yava\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simten","family":"Da\u011fta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve","family":"Kestane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Havva","family":"\u00dcsk\u00fcdar Teke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selami Ko\u00e7ak","family":"Toprak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylin","family":"Karata\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fcnci","family":"Ya\u011fc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00fczg\u00fcn","family":"\u00d6zatl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z\u00fcbeyde Nur","family":"\u00d6zkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"\u0130lhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhlis Cem","family":"Ar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"ref0","unstructured":"1. Stanley M, Killeen RB, Michalski JM. Thrombotic thrombocytopenic purpura. In: StatPearls [Internet]. Treasure Island, StatPearls Publishing, 2023. Available online at https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430721\/."},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Mingot Castellano ME, Pascual Izquierdo C, Gonz\u00e1lez A, Viejo Llorente A, Valcarcel Ferreiras D, Sebasti\u00e1n E, Garc\u00eda Candel F, Sarmiento Palao H, G\u00f3mez Segu\u00ed I, de la Rubia J, Cid J, Mart\u00ednez Nieto J, Hern\u00e1ndez Mateo L, Goterris Viciedo R, Fidalgo T, Salinas R, Del Rio-Garma J; Grupo Espa\u00f1ol de Af\u00e9resis (GEA). Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura. Med Clin (Barc). 2022;158:630.e1-630.e14.","DOI":"10.1016\/j.medcle.2021.03.038"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/rth2.12160","article-title":"Thrombotic thrombocytopenic purpura: toward targeted therapy and precision medicine","volume":"3","author":"Coppo","year":"2019","unstructured":"3. Coppo P, Cuker A, George JN. Thrombotic thrombocytopenic purpura: toward targeted therapy and precision medicine. Res Pract Thromb Haemost. 2019;3:26-37.","journal-title":"Res Pract Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","unstructured":"4. Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood. 2008;112:11-18.","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/17474086.2019.1611423","article-title":"An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura","volume":"12","author":"Joly","year":"2019","unstructured":"5. Joly BS, Coppo P, Veyradier A. An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert Rev Hematol. 2019;12:383-395.","journal-title":"Expert Rev Hematol"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, Galicier L, Lemiale V, Mira JP, Ridel C, Rondeau E, Pourrat J, Girault S, Bordessoule D, Saheb S, Ramakers M, Hamidou M, Vernant JP, Guidet B, Wolf M, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA Reference Center experience. PLoS One. 2010;5:e10208.","DOI":"10.1371\/journal.pone.0010208"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Adeyemi A, Razakariasa F, Chiorean A, de Passos Sousa R. Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune-mediated thrombotic thrombocytopenic purpura in the United States. Res Pract Thromb Haemost. 2022;6:e12802.","DOI":"10.1002\/rth2.12802"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Prov\u00f4t F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet Haematol. 2016;3:e237-e245.","DOI":"10.1016\/S2352-3026(16)30018-7"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","unstructured":"9. Kremer Hovinga JA, Coppo P, L\u00e4mmle B, Moake JL, Miyata T, Vanhoorelbeke K. Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers. 2017;3:17020.","journal-title":"Nat Rev Dis Primers"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/trf.13586","article-title":"Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012","volume":"56","author":"Goel","year":"2016","unstructured":"10. Goel R, King KE, Takemoto CM, Ness PM, Tobian AA. Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012. Transfusion. 2016;56:1451-1458.","journal-title":"Transfusion"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","unstructured":"11. Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ; British Committee for Standards in Haematology. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158:323-335.","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/jca.21302","article-title":"Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research","volume":"29","author":"Sarode","year":"2014","unstructured":"12. Sarode R, Bandarenko N, Brecher ME, Kiss JE, Marques MB, Szczepiorkowski ZM, Winters JL. Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. J Clin Apher. 2014;29:148-167.","journal-title":"J Clin Apher"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","unstructured":"13. Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017;129:2836-2846.","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","unstructured":"14. Kremer Hovinga JA, Vesely SK, Terrell DR, L\u00e4mmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010;115:1500-1511.","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","unstructured":"15. Scully M, Cataland SR, Peyvandi F, Coppo P, Kn\u00f6bl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK; HERCULES Investigators. Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2019;380:335-346.","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/ajh.24339","article-title":"Long-term outcomes of thrombotic microangiopathy treated with plasma exchange: a systematic review","volume":"91","author":"Thejeel","year":"2016","unstructured":"16. Thejeel B, Garg AX, Clark WF, Liu AR, Iansavichus AV, Hildebrand AM. Long-term outcomes of thrombotic microangiopathy treated with plasma exchange: a systematic review. Am J Hematol 2016;91:623-630.","journal-title":"Am J Hematol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/imj.12935","article-title":"Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP\/thrombotic microangiopathy registry","volume":"46","author":"Blombery","year":"2016","unstructured":"17. Blombery P, Kivivali L, Pepperell D, McQuilten Z, Engelbrecht S, Polizzotto MN, Phillips LE, Wood E, Cohney S; TTP registry steering committee. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP\/thrombotic microangiopathy registry. Intern Med J. 2016;46:71-79.","journal-title":"Intern Med J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1055\/s-0039-1679907","article-title":"Clinical and laboratory features of patients with acquired thrombotic thrombocytopenic purpura: fourteen years of the Milan TTP Registry","volume":"119","author":"Mancini","year":"2019","unstructured":"18. Mancini I, Pontiggia S, Palla R, Artoni A, Valsecchi C, Ferrari B, Mikovic D, Peyvandi F; Italian Group of TTP Investigators. Clinical and laboratory features of patients with acquired thrombotic thrombocytopenic purpura: fourteen years of the Milan TTP Registry. Thromb Haemost. 2019;119:695-704.","journal-title":"Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1182\/bloodadvances.2017005124","article-title":"Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015","volume":"1","author":"Page","year":"2017","unstructured":"19. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv. 2017;1:590-600.","journal-title":"Blood Adv"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.transci.2018.02.012","article-title":"A multicenter experience of thrombotic microangiopathies in Turkey: the Turkish Hematology Research and Education Group (ThREG)-TMA01 study","volume":"57","author":"Tekg\u00fcnd\u00fcz","year":"2018","unstructured":"20. Tekg\u00fcnd\u00fcz E, Y\u0131lmaz M, Erkurt MA, Kiki I, Kaya AH, Kaynar L, Alacacioglu I, Cetin G, Ozarslan I, Kuku I, Sincan G, Salim O, Namdaroglu S, Karakus A, Karakus V, Altuntas F, Sari I, Ozet G, Aydogdu I, Okan V, Kaya E, Yildirim R, Yildizhan E, Ozgur G, Ozcebe OI, Payzin B, Akpinar S, Demirkan F. A multicenter experience of thrombotic microangiopathies in Turkey: the Turkish Hematology Research and Education Group (ThREG)-TMA01 study. Transfus Apher Sci. 2018;57:27-30.","journal-title":"Transfus Apher Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"103365","DOI":"10.1016\/j.transci.2022.103365","article-title":"Prospective registry of adult patients receiving TPE with a presumptive diagnosis of thrombotic microangiopathy (TMA): the Turkish Hematology Research and Education Group (ThREG)-TMA02 study","volume":"61","author":"Akpinar","year":"2022","unstructured":"21. Akpinar S, Tekgunduz E, Esen R, Yilmaz M, Karakus V, Vural F, Gediz F, Aydogdu I, Kaynar L, Goker H, Kelkitli E, Ayyildiz O, Demirkan F. Prospective registry of adult patients receiving TPE with a presumptive diagnosis of thrombotic microangiopathy (TMA): the Turkish Hematology Research and Education Group (ThREG)-TMA02 study. Transfus Apher Sci. 2022;61:103365.","journal-title":"Transfus Apher Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1182\/blood.2020009150","article-title":"Redefining outcomes in immune TTP: an international working group consensus report","volume":"137","author":"Cuker","year":"2021","unstructured":"22. Cuker A, Cataland SR, Coppo P, de la Rubia J, Friedman KD, George JN, Knoebl PN, Kremer Hovinga JA, L\u00e4mmle B, Matsumoto M, Pavenski K, Peyvandi F, Sakai K, Sarode R, Thomas MR, Tomiyama Y, Veyradier A, Westwood JP, Scully M. Redefining outcomes in immune TTP: an international working group consensus report. Blood. 2021;137:1855-1861.","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Sadler JE. What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura? Hematology Am Soc Hematol Educ Program. 2015;2015:631-636.","DOI":"10.1182\/asheducation-2015.1.631"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3324\/haematol.2018.198275","article-title":"Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"104","author":"Staley","year":"2019","unstructured":"24. Staley EM, Cao W, Pham HP, Kim CH, Kocher NK, Zheng L, Gangaraju R, Lorenz RG, Williams LA, Marques MB, Zheng XL. Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura. Haematologica. 2019;104:166-175.","journal-title":"Haematologica"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Griffin D, Al-Nouri ZL, Muthurajah D, Ross JR, Ballard RB, Terrell DR, Vesely SK, George JN, Marques MB. First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion. 2013;53:235-237.","DOI":"10.1111\/j.1537-2995.2012.03934.x"},{"key":"ref25","unstructured":"26. Ruggenenti P, Remuzzi G. Pathophysiology and management of thrombotic microangiopathies. J Nephrol. 1998;11:300-310."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features","volume":"142","author":"Scully","year":"2008","unstructured":"27. Scully M, Yarranton H, Liesner R, Cavenagh J, Hunt B, Benjamin S, Bevan D, Mackie I, Machin S. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol. 2008;142:819-826.","journal-title":"Br J Haematol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12185-011-0771-5","article-title":"Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience","volume":"93","author":"Jang","year":"2011","unstructured":"28. Jang MJ, Chong SY, Kim IH, Kim JH, Jung CW, Kim JY, Park JC, Lee SM, Kim YK, Lee JE, Jang SS, Kim JS, Jo DY, Zang DY, Lee YY, Yhim HY, Oh D. Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience. Int J Hematol. 2011;93:163-169.","journal-title":"Int J Hematol"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Contreras E, de la Rubia J, Del R\u00edo-Garma J, D\u00edaz-Ricart M, Garc\u00eda-Gala JM, Lozano M; Grupo Espa\u00f1ol de Af\u00e9resis. Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group. Med Clin (Barc). 2015;144:331.e1-331.e13.","DOI":"10.1016\/j.medcle.2015.11.007"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/jth.12826","article-title":"Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity","volume":"13","author":"Zafrani","year":"2015","unstructured":"30. Zafrani L, Mariotte E, Darmon M, Canet E, Merceron S, Boutboul D, Veyradier A, Galicier L, Azoulay E. Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity. J Thromb Haemost. 2015;13:380-389.","journal-title":"J Thromb Haemost"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/jth.12790","article-title":"Experience of the French Thrombotic Microangiopathies Reference Center","volume":"13","author":"Benhamou","year":"2015","unstructured":"31. Benhamou Y, Boelle PY, Baudin B, Ederhy S, Gras J, Galicier L, Azoulay E, Prov\u00f4t F, Maury E, P\u00e8ne F, Mira JP, Wynckel A, Presne C, Poullin P, Halimi JM, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Hamidou M, Cohen A, Veyradier A, Coppo P; Reference Center for Thrombotic Microangiopathies. Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center. J Thromb Haemost. 2015;13:293-302.","journal-title":"J Thromb Haemost"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1365-2141.2010.08385.x","article-title":"Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura","volume":"151","author":"Lotta","year":"2010","unstructured":"32. Lotta LA, Mariani M, Consonni D, Mancini I, Palla R, Maino A, Vucelic D, Pizzuti M, Mannucci PM, Peyvandi F. Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura. Br J Haematol. 2010;151:488-494.","journal-title":"Br J Haematol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ajh.22091","article-title":"Systemic infections mimicking thrombotic thrombocytopenic purpura","volume":"86","author":"Booth","year":"2011","unstructured":"33. Booth KK, Terrell DR, Vesely SK, George JN. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011;86:743-751.","journal-title":"Am J Hematol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.hemonc.2015.11.003","article-title":"Clopidogrel-induced refractory thrombotic thrombocytopenic purpura successfully treated with rituximab","volume":"9","author":"Khodor","year":"2016","unstructured":"34. Khodor S, Castro M, McNamara C, Chaulagain CP. Clopidogrel-induced refractory thrombotic thrombocytopenic purpura successfully treated with rituximab. Hematol Oncol Stem Cell Ther. 2016;9:76-79.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1182\/bloodadvances.2023011972","article-title":"Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience","volume":"8","author":"B\u00e9ranger","year":"2024","unstructured":"35. B\u00e9ranger N, Coppo P, Tsatsaris V, Boisseau P, Prov\u00f4t F, Delmas Y, Poullin P, Vanhoorelbeke K, Veyradier A, Joly BS. Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience. Blood Adv. 2024;8:183-193.","journal-title":"Blood Adv"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group","volume":"136","author":"Fakhouri","year":"2020","unstructured":"36. Fakhouri F, Scully M, Prov\u00f4t F, Blasco M, Coppo P, Noris M, Paizis K, Kavanagh D, P\u00e8ne F, Quezada S, Hertig A, Kissling S, O'Brien P, Delmas Y, Alberio L, Winer N, Veyradier A, Cataland S, Fr\u00e9meaux-Bacchi V, Loirat C, Remuzzi G, Tsatsaris V. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group. Blood. 2020;136:2103-2117.","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"103749","DOI":"10.1016\/j.transci.2023.103749","article-title":"Predictors of relapse and prophylactic management of immune thrombotic thrombocytopenic purpura","volume":"62","author":"Oliver","year":"2023","unstructured":"37. Oliver M, Patriquin CJ, Pavenski K. Predictors of relapse and prophylactic management of immune thrombotic thrombocytopenic purpura. Transfus Apher Sci. 2023;62:103749.","journal-title":"Transfus Apher Sci"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Zheng XL, Al-Housni Z, Cataland SR, Coppo P, Geldziler B, Germini F, Iorio A, Keepanasseri A, Masias C, Matsumoto M, McCrae KR, McIntyre J, Mustafa RA, Peyvandi F, Russell L, Tarawneh R, Vesely SK; International Society on Thrombosis and Haemostasis. 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura. J Thromb Haemost. (in press). doi: 10.1016\/j.jtha.2025.06.002.","DOI":"10.1016\/j.jtha.2025.06.002"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1200\/JOP.2016.012096","article-title":"Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer","volume":"12","author":"JM","year":"2016","unstructured":"39. Morton JM, George JN. Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer. J Oncol Pract. 2016;12:523-530.","journal-title":"J Oncol Pract"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1182\/bloodadvances.2019031039","article-title":"Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura","volume":"3","author":"Sun","year":"2019","unstructured":"40. Sun L, Mack J, Li A, Ryu J, Upadhyay VA, Uhl L, Kaufman RM, Stowell CP, Dzik WS, Makar RS, Bendapudi PK. Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura. Blood Adv. 2019;3:1512-1518.","journal-title":"Blood Adv"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000524597","article-title":"Effect of blood groups on clinical presentations and treatment outcomes in immune thrombotic thrombocytopenic purpura patients with severe ADAMTS13 deficiency: a multi-center experience","volume":"50","author":"Y\u0131ld\u0131r\u0131m","year":"2022","unstructured":"41. Y\u0131ld\u0131r\u0131m M, Say\u0131n S, G\u00fcne\u015f AK, Reis Aras M, Safak Y\u0131lmaz E, Albayrak M, \u00d6zet G, Ayl\u0131 M. Effect of blood groups on clinical presentations and treatment outcomes in immune thrombotic thrombocytopenic purpura patients with severe ADAMTS13 deficiency: a multi-center experience. Transfus Med Hemother. 2022;50:18-25.","journal-title":"Transfus Med Hemother"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejim.2020.01.024","article-title":"Prevalence of the age-related diseases in older patients with acquired thrombotic thrombocytopenic purpura","volume":"75","author":"Agosti","year":"2020","unstructured":"42. Agosti P, Mancini I, Gianniello F, Bucciarelli P, Artoni A, Ferrari B, Pontiggia S, Trisolini SM, Facchini L, Carbone C, Peyvandi F; Italian Group of TTP Investigators. Prevalence of the age-related diseases in older patients with acquired thrombotic thrombocytopenic purpura. Eur J Intern Med. 2020;75:79-83.","journal-title":"Eur J Intern Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1182\/blood.2019000748","article-title":"Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival","volume":"134","author":"Prevel","year":"2019","unstructured":"43. Prevel R, Roubaud-Baudron C, Gourlain S, Jamme M, Peres K, Benhamou Y, Galicier L, Azoulay E, Poullin P, Prov\u00f4t F, Maury E, Presne C, Hamidou M, Saheb S, Wynckel A, Servais A, Girault S, Delmas Y, Chatelet V, Augusto JF, Mousson C, Perez P, Halimi JM, Kanouni T, Lautrette A, Charvet-Rumpler A, Deligny C, Chauveau D, Veyradier A, Coppo P. Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival. Blood. 2019;134:2209-2217.","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44. Jamme M, Rondeau E. The PLASMIC score for thrombotic thrombocytopenic purpura. Lancet Haematol. 2017;4:e148-e149.","DOI":"10.1016\/S2352-3026(17)30024-8"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/trf.15954","article-title":"Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: a systematic review and meta-analysis","volume":"60","author":"Paydary","year":"2020","unstructured":"45. Paydary K, Banwell E, Tong J, Chen Y, Cuker A. Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: a systematic review and meta-analysis. Transfusion. 2020;60:2047-2057.","journal-title":"Transfusion"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.thromres.2020.05.045","article-title":"Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: a 10-year provincial retrospective cohort study","volume":"193","author":"Sawler","year":"2020","unstructured":"46. Sawler D, Parker A, Britto J, Goodyear MD, Sun HL. Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: a 10-year provincial retrospective cohort study. Thromb Res. 2020;193:53-59.","journal-title":"Thromb Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jca.21489","article-title":"How we treat thrombotic thrombocytopenic purpura: results of a Canadian TTP practice survey","volume":"32","author":"CJ","year":"2017","unstructured":"47. Patriquin CJ, Clark WF, Pavenski K, Arnold DM, Rock G, Foley SR; Canadian Apheresis Group. How we treat thrombotic thrombocytopenic purpura: results of a Canadian TTP practice survey. J Clin Apher. 2017;32:246-256.","journal-title":"J Clin Apher"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1182\/blood-2006-02-006064","article-title":"Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity","volume":"109","author":"Ferrari","year":"2007","unstructured":"48. Ferrari S, Scheiflinger F, Rieger M, Mudde G, Wolf M, Coppo P, Girma JP, Azoulay E, Brun-Buisson C, Fakhouri F, Mira JP, Oksenhendler E, Poullin P, Rondeau E, Schleinitz N, Schlemmer B, Teboul JL, Vanhille P, Vernant JP, Meyer D, Veyradier A; French Clinical and Biological Network on Adult Thrombotic Microangiopathies. Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity. Blood. 2007;109:2815-2822.","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1182\/blood-2014-01-550244","article-title":"Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura","volume":"124","author":"Hie","year":"2014","unstructured":"49. Hie M, Gay J, Galicier L, Prov\u00f4t F, Presne C, Poullin P, Bonmarchand G, Wynckel A, Benhamou Y, Vanhille P, Servais A, Bordessoule D, Coindre JP, Hamidou M, Vernant JP, Veyradier A, Coppo P; French Thrombotic Microangiopathies Reference Centre. Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura. Blood. 2014;124:204-210.","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"50. Masias C, Wu H, McGookey M, Jay L, Cataland S, Yang S. No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: the experience from the Ohio State University Registry. Am J Hematol. 2018;93:E73-E75.","DOI":"10.1002\/ajh.25002"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1182\/asheducation-2018.1.548","article-title":"TTP: long-term outcomes following recovery","volume":"2018","author":"George","year":"2018","unstructured":"51. George JN. TTP: long-term outcomes following recovery. Hematology Am Soc Hematol Educ Program. 2018;2018:548-552.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1537-2995.2008.01938.x","article-title":"Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura","volume":"49","author":"Lewis","year":"2009","unstructured":"52. Lewis QF, Lanneau MS, Mathias SD, Terrell DR, Vesely SK, George JN. Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009;49:118-124.","journal-title":"Transfusion"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2215\/CJN.11470918","article-title":"Etiology and outcomes of thrombotic microangiopathies","volume":"14","author":"Bayer","year":"2019","unstructured":"53. Bayer G, von Tokarski F, Thoreau B, Bauvois A, Barbet C, Cloarec S, M\u00e9rieau E, Lachot S, Garot D, Bernard L, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Buchler M, Vigneau C, Fakhouri F, Halimi JM. Etiology and outcomes of thrombotic microangiopathies. Clin J Am Soc Nephrol. 2019;14:557-566.","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"100062","DOI":"10.1016\/j.tru.2021.100062","article-title":"Updates on thrombotic thrombocytopenic purpura: recent developments in pathogenesis, treatment and survivorship","volume":"5","author":"Sukumar","year":"2021","unstructured":"54. Sukumar S, Gavriilaki E, Chaturvedi S. Updates on thrombotic thrombocytopenic purpura: recent developments in pathogenesis, treatment and survivorship. Thromb Update. 2021;5:100062.","journal-title":"Thromb Update"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"55. Vesely SK. Life after acquired thrombotic thrombocytopenic purpura: morbidity, mortality, and risks during pregnancy. J Thromb Haemost. 2015;13(Suppl 1):S216-S222.","DOI":"10.1111\/jth.12953"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T14:24:20Z","timestamp":1756736660000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-25307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":55,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2025.2025.0134","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"type":"print","value":"1300-7777"},{"type":"electronic","value":"1308-5263"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}